These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7401119)

  • 21. Clinical trial of nafoxidine in adrenalectomized patients with advanced breast cancer.
    Jain J; Samal B; Singhakowinta A; Vaitkevicius VK
    Cancer; 1977 Nov; 40(5):2063-6. PubMed ID: 336179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroidal antiestrogens induce apoptosis in HL60 and MOLT3 leukemic cells; involvement of reactive oxygen radicals and protein kinase C.
    Hayon T; Dvilansky A; Oriev L; Nathan I
    Anticancer Res; 1999; 19(3A):2089-93. PubMed ID: 10470153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK; Boldt DH; Estrada P
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular structures and conformational studies of triarylcyclopropyl and related nonsteroidal antiestrogens.
    Hossain MB; van der Helm D; Schmitz FJ; Pordesimo EO; Magarian RA; Meyer KL; Overacre LB; Day BW
    J Med Chem; 1994 May; 37(11):1670-83. PubMed ID: 8201601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of angiogenesis by antiestrogens.
    Gagliardi A; Collins DC
    Cancer Res; 1993 Feb; 53(3):533-5. PubMed ID: 7678775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
    Sato M; Rippy MK; Bryant HU
    FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values. A phase II study.
    Moseson DL; Sasaki GH; Kraybill WG; Leung BS; Davenport CE; Fletcher WS
    Cancer; 1978 Mar; 41(3):797-802. PubMed ID: 638966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the estradiol-induced luteinizing hormone surge by progesterone or antiestrogens: effects on pituitary gonadotropin-releasing hormone receptors.
    Attardi B; Happe HK
    Endocrinology; 1986 Jul; 119(1):274-83. PubMed ID: 3013589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated cyclophosphamide anticancer drugs: molecular structures of cis- and trans-4-hydroperoxyisophosphamides.
    Camerman A; Smith HW; Camerman N
    J Med Chem; 1983 May; 26(5):679-83. PubMed ID: 6842507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA-binding antibiotics. X-ray structure of the distamycin A analog.
    Gurskaya GV; Grokhovsky SL; Zhuze AL; Gottikh BP
    Biochim Biophys Acta; 1979 Jul; 563(2):336-42. PubMed ID: 465494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structure of N-[3-phenyl-5-(1,2,3,4-oxatriazolio)]-phenylamide at 105 K.
    Ottersen T; Christophersen C; Treppendahl S
    Acta Chem Scand A; 1975; 29(1):45-50. PubMed ID: 1138522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
    Gottardis MM; Ricchio ME; Satyaswaroop PG; Jordan VC
    Cancer Res; 1990 Jun; 50(11):3189-92. PubMed ID: 2334915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.
    Valentin-Opran A; Eilon G; Saez S; Mundy GR
    J Clin Invest; 1985 Feb; 75(2):726-31. PubMed ID: 3855865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
    Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
    J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of intracellular equilibria and the effect of antiestrogens on estrogen-receptor dissociation kinetics from perfused cultures of human breast cancer cells.
    Strobl JS; Monaco ME; Lippman ME
    Endocrinology; 1980 Aug; 107(2):450-60. PubMed ID: 7389663
    [No Abstract]   [Full Text] [Related]  

  • 36. Gap junction modulation in rat uterus. II. Effects of antiestrogens on myometrial and serosal cells.
    Burghardt RC; Mitchell PA; Kurten R
    Biol Reprod; 1984 Feb; 30(1):249-55. PubMed ID: 6421335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
    Attardi B; Palumbo LA
    Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic value of nafoxidine hydrochloride in the treatment of advanced carcinoma of the human breast.
    Sasaki GH; Leung BS; Fletcher WS
    Surg Gynecol Obstet; 1976 Apr; 142(4):560-4. PubMed ID: 1257870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
    Ferguson ER; Katzenellenbogen BS
    Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig.
    Gulino A; Pasqualini JR
    Cancer Res; 1980 Oct; 40(10):3821-6. PubMed ID: 7438065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.